These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


366 related items for PubMed ID: 789010

  • 1. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH.
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 85Sr, 87mSr, 18F, and 99mTc-labeled phosphates for bone scanning.
    Marty R, Denney JD, McKamey MR, Rowley MJ.
    CRC Crit Rev Clin Radiol Nucl Med; 1975 Jul; 6(3):403-23. PubMed ID: 168034
    [Abstract] [Full Text] [Related]

  • 3. 99mTc-polyphosphate and 99mTc-diphosphonate bone scintigraphy in neurosurgical practice.
    Handa J, Yamamoto I, Morita R, Kousaka T, Fujita T, Handa H.
    Surg Neurol; 1974 Sep; 2(5):307-10. PubMed ID: 4528122
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of technetium-99m diphosphonate.
    Castronovo FP, Guiberteau MJ, Berg G, McKusick KA, Callahan RJ, Potsaid MS.
    J Nucl Med; 1977 Aug; 18(8):809-14. PubMed ID: 874170
    [Abstract] [Full Text] [Related]

  • 5. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
    Subramanian G, McAfee JG, Blair RJ, Rosenstreich M, Coco M, Duxbury CE.
    J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
    [Abstract] [Full Text] [Related]

  • 6. Bone scintigraphy with 99mTc-labelled polyphosphate.
    Edeling CJ.
    Nucl Med (Stuttg); 1974 Aug 31; 13(2):113-26. PubMed ID: 4612487
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of skull imaging in routine bone scanning.
    Coleman RE, Bernier DR, Pasternak S, Siegel BA.
    J Nucl Med; 1974 Dec 31; 15(12):1185-6. PubMed ID: 4427148
    [No Abstract] [Full Text] [Related]

  • 8. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD.
    J Nucl Med; 1975 Aug 31; 16(8):744-55. PubMed ID: 170385
    [Abstract] [Full Text] [Related]

  • 9. Significant differences amont the 99mTc-polyphosphates, 99mTc-pyrophosphates, and 99mTc-diphosphonates for bone imaging.
    Weber DA, Keyes JW, Wilson GA.
    CRC Crit Rev Clin Radiol Nucl Med; 1977 Jan 31; 8(4):369-90. PubMed ID: 189966
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of 99mTc-polyphosphate and 18F. II. Imaging.
    Krishnamurthy GT, Walsh CF, Shoop LE, Berger HG, Blahd WH.
    J Nucl Med; 1974 Oct 31; 15(10):837-43. PubMed ID: 4417868
    [No Abstract] [Full Text] [Related]

  • 11. Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans.
    Tofe AJ, Francis MD, Harvey WJ.
    J Nucl Med; 1975 Nov 31; 16(11):986-9. PubMed ID: 810549
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of 99mTc-labeled monofluorophosphate: a comparison with ethane-hydroxy-diphosphonate.
    Citrin DL, Bessent RG, Greig WR.
    J Nucl Med; 1974 Dec 31; 15(12):1110-2. PubMed ID: 4427134
    [No Abstract] [Full Text] [Related]

  • 13. [Bone scintigraphy in neurosurgical practice (author's transl)].
    Handa J, Handa H, Yamamoto I, Morita R, Kousaka T.
    No Shinkei Geka; 1975 May 31; 3(5):399-405. PubMed ID: 1060919
    [Abstract] [Full Text] [Related]

  • 14. [Technetium polyphosphate and technetium diphosphonate. A comparative study].
    Henne W, Pixberg HU, Pfannenstiel P.
    Nucl Med (Stuttg); 1975 Jun 30; 14(2):83-90. PubMed ID: 1178518
    [Abstract] [Full Text] [Related]

  • 15. Two unusual causes of peripatellar nonmetastatic positive bone scans in patients with malignancies: case reports.
    Turner JW, Syed IB, Spencer RP.
    J Nucl Med; 1976 Aug 30; 17(8):693-5. PubMed ID: 932812
    [Abstract] [Full Text] [Related]

  • 16. Radionuclide bone imaging.
    Koenigsberg M, Freeman LM.
    Curr Probl Diagn Radiol; 1976 Aug 30; 6(5):1-54. PubMed ID: 797529
    [No Abstract] [Full Text] [Related]

  • 17. Bone-to-bone, joint-to-bone and joint-to-joint ratios in normal and diseased skeletal states using region-of-interest technique and bone-seeking radiopharmaceuticals.
    Büll U, Schuster H, Pfeifer JP, Tongendorff J, Niendorf HP.
    Nuklearmedizin; 1977 Jul 30; 16(3):104-12. PubMed ID: 197499
    [Abstract] [Full Text] [Related]

  • 18. [250 STUDIES OF BONE RADIOISOTOPE SCANNING BY TIN PYROPHOSPHATE LABELLED WITH TECHNETIUM 99M. Analytical and critical study].
    Rampon S, Bussière JL, Prin P, Sauvezie B, Leroy V, Missioux D, Doly J, Suss P, Jourde H, Lapalus F.
    Rev Rhum Mal Osteoartic; 1974 Dec 30; 41(12):745-51. PubMed ID: 4376256
    [No Abstract] [Full Text] [Related]

  • 19. Bone scanning in evaluation of Paget's disease of bone.
    Shirazi PH, Ryan WG, Fordham EW.
    CRC Crit Rev Clin Radiol Nucl Med; 1974 Oct 30; 5(4):523-58. PubMed ID: 4279805
    [No Abstract] [Full Text] [Related]

  • 20. Technetium-99m-glucoheptonate as a brain-scanning agent: critical comparison with pertechnetate.
    Waxman AD, Tanacescu D, Siemsen JK, Wolfstein RS.
    J Nucl Med; 1976 May 30; 17(5):345-8. PubMed ID: 1262934
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.